.svg)
You've probably heard NAD+ described as the molecule that powers your cells, declines with age, and can be restored with the right supplement. The wellness industry has latched onto nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) as anti-aging breakthroughs, but the clinical evidence is still catching up to the hype. Some studies show metabolic benefits. Others show minimal effect. And the question of whether raising NAD+ levels actually translates to longer, healthier life in humans remains open.
Superpower insight: Members who track their metabolic and inflammatory biomarkers over time are better positioned to see whether NAD+ supplementation is producing measurable changes in their biology, not just theoretical benefits.
What NAD+ Actually Does in the Body
Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme found in every living cell. It exists in two forms: NAD+ (oxidized) and NADH (reduced). The constant cycling between these two states allows NAD+ to shuttle electrons during metabolic reactions, making it essential for converting food into usable energy. Without adequate NAD+, mitochondria cannot efficiently produce ATP, the molecule that fuels cellular work.
Beyond energy metabolism, NAD+ serves as a substrate for enzymes called sirtuins and PARPs (poly ADP-ribose polymerases). Sirtuins regulate gene expression, DNA repair, and stress resistance. PARPs repair damaged DNA and help maintain genomic stability. Both enzyme families consume NAD+ to function, which means cellular NAD+ availability directly influences how well your cells can repair themselves and respond to stress.
. This decline is driven by increased consumption (more DNA damage requires more repair), reduced synthesis (the enzymes that make NAD+ become less efficient), and increased degradation (the enzyme CD38, which breaks down NAD+, becomes more active with age). The result is a cellular energy deficit that contributes to mitochondrial dysfunction, impaired DNA repair, and metabolic decline.
What are NAD supplements? They are compounds that your body can convert into NAD+. Rather than supplementing NAD+ directly (which is poorly absorbed and rapidly degraded), these precursors provide the raw materials your cells use to synthesize NAD+ through salvage pathways. The two most studied precursors are nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are intermediates in the NAD+ biosynthesis pathway, sitting one or two enzymatic steps away from becoming NAD+.
How NAD+ Precursors Affect Cellular Function and Metabolism
Energy production and mitochondrial health
. In humans, the effects are more variable. Some trials show improved muscle function and insulin sensitivity, while others show no significant change in physical performance.
DNA repair and cellular stress response
. Human data is limited, but early trials suggest that NAD+ precursors may reduce markers of inflammation and oxidative stress in older adults.
Metabolic regulation and insulin sensitivity
. Human trials have shown modest improvements in insulin sensitivity in some populations, particularly those with prediabetes or metabolic syndrome, though results are inconsistent across studies.
Cardiovascular and endothelial function
. Other studies have found no significant cardiovascular benefit, suggesting that individual response may depend on baseline vascular health and NAD+ status.
What the Clinical Evidence Shows About NAD+ Supplementation
Human trials on NAD+ precursors have produced mixed results. Both NMN and NR reliably raise blood NAD+ levels, but whether this translates to meaningful health outcomes depends on the population studied, the dose used, and the endpoints measured.
. However, the study did not find significant improvements in insulin sensitivity, blood pressure, or cholesterol. A 2021 randomized controlled trial published in Science found that 250 mg of NMN daily for 10 weeks improved skeletal muscle insulin sensitivity and increased muscle NAD+ levels in postmenopausal women with prediabetes. A 2024 systematic review and meta-analysis of NMN trials found that short-term supplementation (250–2,000 mg/day) did not show significantly positive impacts on glucose control or lipid profile in healthy adults, suggesting benefits may be population-specific.
The variability in outcomes suggests that NAD+ supplementation may be most effective in people with existing metabolic dysfunction or low baseline NAD+ levels. Healthy, younger individuals with adequate NAD+ may see little benefit. Older adults, people with insulin resistance, or those with chronic inflammation may respond more favorably. The challenge is that most people don't know their baseline NAD+ status, making it difficult to predict who will benefit.
. Whether similar benefits occur in humans over decades of use remains unknown.
Dosing, Timing, and Supplement Form
Studied dose ranges
Human trials have used NMN doses ranging from 250 mg to 1,200 mg per day, with most studies using 500 to 1,000 mg. NR trials have used doses between 300 mg and 2,000 mg per day, with 1,000 mg being the most common. Higher doses do not always produce better outcomes. Some studies suggest that 250 to 500 mg of NMN may be as effective as higher doses for raising NAD+ levels, though individual absorption and metabolism vary.
Timing and absorption
.
NMN vs. NR: Does the form matter?
. In practice, both precursors raise NAD+ levels in human trials, and no head-to-head study has definitively shown one to be superior. NR has more published human safety data, while NMN has gained more attention in recent years due to animal studies showing robust metabolic effects.
Who Should Use Caution and Why Responses Vary
. These effects are more likely at doses above 1,000 mg per day. Serious adverse events have not been reported in published trials, though long-term safety data beyond 12 weeks is limited.
Individual response to NAD+ precursors varies based on several factors:
- Baseline NAD+ levels: People with lower NAD+ at baseline may experience more noticeable benefits from supplementation.
- Age: Older adults with age-related NAD+ decline may respond more favorably than younger individuals with adequate NAD+ stores.
- Metabolic health: Those with insulin resistance, prediabetes, or metabolic syndrome may see greater improvements in glucose metabolism and insulin sensitivity.
- Genetic differences: Variants in genes encoding NAD+ biosynthesis enzymes (such as NAMPT) may influence how efficiently the body converts precursors to NAD+.
- Gut microbiome: Certain gut bacteria can degrade NAD+ precursors before absorption, reducing bioavailability.
. Individuals with autoimmune conditions should also proceed carefully, as boosting NAD+ may enhance immune cell activity. Those taking medications that affect blood sugar, blood pressure, or liver function should monitor relevant biomarkers closely, as NAD+ precursors may influence these pathways.
How Biomarkers Reveal Whether NAD+ Supplementation Is Working
The most direct way to assess NAD+ supplementation is to measure NAD+ levels in blood or tissue, but this test is not widely available in clinical practice. Instead, tracking related biomarkers can provide insight into whether supplementation is influencing the metabolic and cellular pathways NAD+ regulates.
- Fasting glucose and hemoglobin A1c: Reflect long-term glucose control and insulin sensitivity, both influenced by NAD+-dependent metabolic pathways.
- Insulin and insulin resistance score: Show how efficiently cells respond to insulin, a process regulated by sirtuins.
- Triglycerides and HDL cholesterol: Indicate lipid metabolism and cardiovascular risk, both affected by NAD+-dependent fat oxidation.
- High-sensitivity C-reactive protein (hs-CRP): Measures systemic inflammation, which NAD+ precursors may reduce through improved cellular stress response.
- ALT and AST: Liver enzymes that reflect hepatic function, which NAD+ supports through detoxification and fat metabolism.
Tracking these markers before starting supplementation and again after 8 to 12 weeks provides a clearer picture of whether NAD+ precursors are producing measurable metabolic changes. Directionality matters more than any single value. If fasting glucose trends downward, insulin sensitivity improves, or inflammation markers drop, supplementation may be having a functional effect. If biomarkers remain unchanged, the supplement may not be addressing a limiting factor in your physiology.
The Smarter Way to Evaluate Your NAD+ Status
NAD+ supplementation is not a universal solution. It works best when NAD+ depletion is a limiting factor in cellular function, which is more common in older adults, people with metabolic dysfunction, or those under chronic stress. If you're considering NMN or NR, Superpower's 100+ biomarker panel includes the metabolic, inflammatory, and liver markers that reveal whether your body is functioning in a way that would benefit from NAD+ restoration. Testing before and after supplementation removes the guesswork and shows whether the investment is producing real, measurable change in your physiology.
What NAD+ Actually Does in the Body
Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme found in every living cell. It exists in two forms: NAD+ (oxidized) and NADH (reduced). The constant cycling between these two states allows NAD+ to shuttle electrons during metabolic reactions, making it essential for converting food into usable energy. Without adequate NAD+, mitochondria cannot efficiently produce ATP, the molecule that fuels cellular work.
Beyond energy metabolism, NAD+ serves as a substrate for enzymes called sirtuins and PARPs (poly ADP-ribose polymerases). Sirtuins regulate gene expression, DNA repair, and stress resistance. PARPs repair damaged DNA and help maintain genomic stability. Both enzyme families consume NAD+ to function, which means cellular NAD+ availability directly influences how well your cells can repair themselves and respond to stress.
. This decline is driven by increased consumption (more DNA damage requires more repair), reduced synthesis (the enzymes that make NAD+ become less efficient), and increased degradation (the enzyme CD38, which breaks down NAD+, becomes more active with age). The result is a cellular energy deficit that contributes to mitochondrial dysfunction, impaired DNA repair, and metabolic decline.
What are NAD supplements? They are compounds that your body can convert into NAD+. Rather than supplementing NAD+ directly (which is poorly absorbed and rapidly degraded), these precursors provide the raw materials your cells use to synthesize NAD+ through salvage pathways. The two most studied precursors are nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are intermediates in the NAD+ biosynthesis pathway, sitting one or two enzymatic steps away from becoming NAD+.
How NAD+ Precursors Affect Cellular Function and Metabolism
Energy production and mitochondrial health
. In humans, the effects are more variable. Some trials show improved muscle function and insulin sensitivity, while others show no significant change in physical performance.
DNA repair and cellular stress response
. Human data is limited, but early trials suggest that NAD+ precursors may reduce markers of inflammation and oxidative stress in older adults.
Metabolic regulation and insulin sensitivity
. Human trials have shown modest improvements in insulin sensitivity in some populations, particularly those with prediabetes or metabolic syndrome, though results are inconsistent across studies.
Cardiovascular and endothelial function
. Other studies have found no significant cardiovascular benefit, suggesting that individual response may depend on baseline vascular health and NAD+ status.
What the Clinical Evidence Shows About NAD+ Supplementation
Human trials on NAD+ precursors have produced mixed results. Both NMN and NR reliably raise blood NAD+ levels, but whether this translates to meaningful health outcomes depends on the population studied, the dose used, and the endpoints measured.
. However, the study did not find significant improvements in insulin sensitivity, blood pressure, or cholesterol. A 2021 randomized controlled trial published in Science found that 250 mg of NMN daily for 10 weeks improved skeletal muscle insulin sensitivity and increased muscle NAD+ levels in postmenopausal women with prediabetes. A 2024 systematic review and meta-analysis of NMN trials found that short-term supplementation (250–2,000 mg/day) did not show significantly positive impacts on glucose control or lipid profile in healthy adults, suggesting benefits may be population-specific.
The variability in outcomes suggests that NAD+ supplementation may be most effective in people with existing metabolic dysfunction or low baseline NAD+ levels. Healthy, younger individuals with adequate NAD+ may see little benefit. Older adults, people with insulin resistance, or those with chronic inflammation may respond more favorably. The challenge is that most people don't know their baseline NAD+ status, making it difficult to predict who will benefit.
. Whether similar benefits occur in humans over decades of use remains unknown.
Dosing, Timing, and Supplement Form
Studied dose ranges
Human trials have used NMN doses ranging from 250 mg to 1,200 mg per day, with most studies using 500 to 1,000 mg. NR trials have used doses between 300 mg and 2,000 mg per day, with 1,000 mg being the most common. Higher doses do not always produce better outcomes. Some studies suggest that 250 to 500 mg of NMN may be as effective as higher doses for raising NAD+ levels, though individual absorption and metabolism vary.
Timing and absorption
.
NMN vs. NR: Does the form matter?
. In practice, both precursors raise NAD+ levels in human trials, and no head-to-head study has definitively shown one to be superior. NR has more published human safety data, while NMN has gained more attention in recent years due to animal studies showing robust metabolic effects.
Who Should Use Caution and Why Responses Vary
. These effects are more likely at doses above 1,000 mg per day. Serious adverse events have not been reported in published trials, though long-term safety data beyond 12 weeks is limited.
Individual response to NAD+ precursors varies based on several factors:
- Baseline NAD+ levels: People with lower NAD+ at baseline may experience more noticeable benefits from supplementation.
- Age: Older adults with age-related NAD+ decline may respond more favorably than younger individuals with adequate NAD+ stores.
- Metabolic health: Those with insulin resistance, prediabetes, or metabolic syndrome may see greater improvements in glucose metabolism and insulin sensitivity.
- Genetic differences: Variants in genes encoding NAD+ biosynthesis enzymes (such as NAMPT) may influence how efficiently the body converts precursors to NAD+.
- Gut microbiome: Certain gut bacteria can degrade NAD+ precursors before absorption, reducing bioavailability.
. Individuals with autoimmune conditions should also proceed carefully, as boosting NAD+ may enhance immune cell activity. Those taking medications that affect blood sugar, blood pressure, or liver function should monitor relevant biomarkers closely, as NAD+ precursors may influence these pathways.
How Biomarkers Reveal Whether NAD+ Supplementation Is Working
The most direct way to assess NAD+ supplementation is to measure NAD+ levels in blood or tissue, but this test is not widely available in clinical practice. Instead, tracking related biomarkers can provide insight into whether supplementation is influencing the metabolic and cellular pathways NAD+ regulates.
- Fasting glucose and hemoglobin A1c: Reflect long-term glucose control and insulin sensitivity, both influenced by NAD+-dependent metabolic pathways.
- Insulin and insulin resistance score: Show how efficiently cells respond to insulin, a process regulated by sirtuins.
- Triglycerides and HDL cholesterol: Indicate lipid metabolism and cardiovascular risk, both affected by NAD+-dependent fat oxidation.
- High-sensitivity C-reactive protein (hs-CRP): Measures systemic inflammation, which NAD+ precursors may reduce through improved cellular stress response.
- ALT and AST: Liver enzymes that reflect hepatic function, which NAD+ supports through detoxification and fat metabolism.
Tracking these markers before starting supplementation and again after 8 to 12 weeks provides a clearer picture of whether NAD+ precursors are producing measurable metabolic changes. Directionality matters more than any single value. If fasting glucose trends downward, insulin sensitivity improves, or inflammation markers drop, supplementation may be having a functional effect. If biomarkers remain unchanged, the supplement may not be addressing a limiting factor in your physiology.
The Smarter Way to Evaluate Your NAD+ Status
NAD+ supplementation is not a universal solution. It works best when NAD+ depletion is a limiting factor in cellular function, which is more common in older adults, people with metabolic dysfunction, or those under chronic stress. If you're considering NMN or NR, Superpower's 100+ biomarker panel includes the metabolic, inflammatory, and liver markers that reveal whether your body is functioning in a way that would benefit from NAD+ restoration. Testing before and after supplementation removes the guesswork and shows whether the investment is producing real, measurable change in your physiology.
.avif)